Atlas Trials

Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis

Clinical trial NCT02197767 · COMPLETED

Trial details

NCT number
NCT02197767
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fibrillary Glomerulonephritis
Start date
2014-11-01
Primary completion
2017-04-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.